personalized medicine Archives
Apr. 30, 2014—A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
Mar. 14, 2013—VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.
Sep. 6, 2012—The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.
Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
Apr. 15, 2011—Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science and clinical medicine to the solution of critical problems in patient care. Bedside checklists and electronic “dashboards” developed at Vanderbilt, for example, enable doctors and nurses to chart in exquisite...
Mar. 3, 2011—A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials.
Sep. 30, 2010—Watch video of a Sept. 29, 2010, Lunch and Learn Event with Dr. Jeff Balser, vice chancellor for health affairs, Vanderbilt University Medical Center. Too often, physicians must base life-and-death decisions not on how an individual will respond to therapy but instead on how large groups of patients did — on average — under similar...